Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

NCT03538626 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

HIV Antibodies

Interventions

BIOLOGICAL: VRC-HIVMAB091-00-AB
BIOLOGICAL: rHuPH20

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)